Latest Articles & Resources FEATURED Amarna Therapeutics Strengthens Manufacturing Collaboration with NorthX Biologics Read More » Amarna Therapeutics Strengthens Manufacturing Collaboration with NorthX Biologics Read More » LATEST NEWS + INTERVIEWS Theratechnologies to Be Acquired by Future Pak Almac Completes Cold Chain Expansion at Craigavon HQ Circio Expands Stockholm Lab to Advance Circular RNA Drug Development Biosynth Opens Expanded GMP Bioconjugation Facility in Berlin European Small Molecule Manufacturing at Critical Juncture as Green Rules Meet Market Reality BioSpring Breaks Ground on One of World’s Largest Nucleic Acid API Sites in Germany WuXi XDC Achieves Mechanical Completion of 25,000 m² Singapore Bioconjugate Site Merck KGaA Completes Acquisition of SpringWorks Therapeutics Axplora Invests €35M to Expand Farmabios Site in Italy Kaneka Eurogentec’s New GMP mRNA Facility Now Ready for Vaccine and Gene Therapy Production Hikma Pharmaceuticals to Invest $1B in US Manufacturing by 2030 Aenova to Launch 6,500m³ Cold Chain Facility at Latina Site by 2026 WuXi Biologics Launches High-Concentration Formulation Platform WuXiHigh™2.0 Particle Dynamics Expands CDMO Network with Acquisition of UK Spray Drying Facility Simtra BioPharma Solutions Completes Injectable Manufacturing Expansion in Germany Piramal Pharma Announces $90M Expansion of U.S. CDMO Facilities US Vaccine Policy Disruption Creates Uncertainty for Fall 2025 Season Orano Med Doubles Clinical Supply Capacity at Plano Facility Torrent Pharmaceuticals Expands into CDMO with JB Pharma Merger Vetter Breaks Ground on $285M Des Plaines Clinical Manufacturing Facility Supply Chain Disruptions Contribute to Heightened Global Market Volatility in Q2 2025 PODCAST INTERVIEWS European Small Molecule Manufacturing at Critical Juncture as Green Rules Meet Market Reality 10 Things I’d Do Differently When Fast Tracking Emergency Drug Manufacturing How To Build Biotechs from First Principles: Deep Science Ventures’ Formula for Science-based Innovation
How To Build Biotechs from First Principles: Deep Science Ventures’ Formula for Science-based Innovation